Wednesday, June 29, 2005

Bextra: Still suspended in Europe

Europe's drug agency concluded a review of COX-2 painkillers, and said on June 27, 2005 it will recommend the continued suspension of Pfizer Inc.'s Bextra drug.

The London-based European Medicines Agency said it would review the suspension of Bextra, which was first suspended in Europe and the United States in April, within one year.